HEADER OXIDOREDUCTASE 27-AUG-21 7RZL TITLE CRYSTAL STRUCTURE OF PUTATIVE NAD(P)H-FLAVIN OXIDOREDUCTASE FROM TITLE 2 HAEMOPHILUS INFLUENZAE R2846 IN COMPLEX WITH 4-NITROPHENOL COMPND MOL_ID: 1; COMPND 2 MOLECULE: NAD(P)H-DEPENDENT OXIDOREDUCTASE; COMPND 3 CHAIN: A; COMPND 4 EC: 1.6.5.2; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: NAD(P)H-DEPENDENT OXIDOREDUCTASE; COMPND 8 CHAIN: B; COMPND 9 EC: 1.6.5.2; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HAEMOPHILUS INFLUENZAE R2846; SOURCE 3 ORGANISM_TAXID: 262727; SOURCE 4 GENE: CH638_05260; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_VARIANT: GOLD; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HAEMOPHILUS INFLUENZAE R2846; SOURCE 10 ORGANISM_TAXID: 262727; SOURCE 11 GENE: CH638_05260; SOURCE 12 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 13 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 14 EXPRESSION_SYSTEM_VARIANT: GOLD KEYWDS OXIDOREDUCTASE, STRUCTURAL GENOMICS, CENTER FOR STRUCTURAL GENOMICS KEYWDS 2 OF INFECTIOUS DISEASES, CSGID EXPDTA X-RAY DIFFRACTION AUTHOR N.MALTSEVA,Y.KIM,M.ENDRES,T.CROFTS,A.JOACHIMIAK,CENTER FOR STRUCTURAL AUTHOR 2 GENOMICS OF INFECTIOUS DISEASES (CSGID) REVDAT 1 29-SEP-21 7RZL 0 JRNL AUTH N.MALTSEVA,Y.KIM,M.ENDRES,T.CROFTS,A.JOACHIMIAK JRNL TITL CRYSTAL STRUCTURE OF PUTATIVE NAD(P)H-FLAVIN OXIDOREDUCTASE JRNL TITL 2 FROM HAEMOPHILUS INFLUENZAE R2846 IN COMPLEX WITH JRNL TITL 3 4-NITROPHENOL JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.45 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19_4092 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.45 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.11 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.370 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.0 REMARK 3 NUMBER OF REFLECTIONS : 68981 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.150 REMARK 3 R VALUE (WORKING SET) : 0.148 REMARK 3 FREE R VALUE : 0.190 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.950 REMARK 3 FREE R VALUE TEST SET COUNT : 3183 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 40.1100 - 4.1200 1.00 3061 166 0.1772 0.1977 REMARK 3 2 4.1200 - 3.2700 1.00 2951 150 0.1446 0.1866 REMARK 3 3 3.2700 - 2.8600 1.00 2905 149 0.1660 0.1907 REMARK 3 4 2.8600 - 2.6000 1.00 2861 168 0.1680 0.2187 REMARK 3 5 2.6000 - 2.4100 1.00 2905 148 0.1609 0.1838 REMARK 3 6 2.4100 - 2.2700 1.00 2869 128 0.1449 0.1772 REMARK 3 7 2.2700 - 2.1500 1.00 2867 142 0.1319 0.1845 REMARK 3 8 2.1500 - 2.0600 1.00 2867 150 0.1324 0.1711 REMARK 3 9 2.0600 - 1.9800 1.00 2863 139 0.1321 0.1729 REMARK 3 10 1.9800 - 1.9100 1.00 2837 150 0.1257 0.2137 REMARK 3 11 1.9100 - 1.8500 1.00 2823 174 0.1307 0.1762 REMARK 3 12 1.8500 - 1.8000 1.00 2829 142 0.1255 0.1933 REMARK 3 13 1.8000 - 1.7500 1.00 2859 144 0.1308 0.1887 REMARK 3 14 1.7500 - 1.7100 1.00 2829 141 0.1281 0.1644 REMARK 3 15 1.7100 - 1.6700 1.00 2849 146 0.1241 0.1628 REMARK 3 16 1.6700 - 1.6400 1.00 2796 153 0.1202 0.1815 REMARK 3 17 1.6400 - 1.6000 1.00 2853 138 0.1188 0.1816 REMARK 3 18 1.6000 - 1.5700 0.99 2799 168 0.1259 0.1938 REMARK 3 19 1.5700 - 1.5400 0.98 2773 136 0.1374 0.2097 REMARK 3 20 1.5400 - 1.5200 0.90 2540 127 0.1463 0.2005 REMARK 3 21 1.5200 - 1.4900 0.72 2008 108 0.1508 0.2328 REMARK 3 22 1.4900 - 1.4700 0.48 1340 75 0.1600 0.2135 REMARK 3 23 1.4700 - 1.4500 0.31 891 41 0.1574 0.2213 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.113 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 17.353 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 12.15 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.27 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 4102 REMARK 3 ANGLE : 1.026 5566 REMARK 3 CHIRALITY : 0.085 570 REMARK 3 PLANARITY : 0.009 730 REMARK 3 DIHEDRAL : 11.516 630 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7RZL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-AUG-21. REMARK 100 THE DEPOSITION ID IS D_1000259282. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-FEB-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97890 REMARK 200 MONOCHROMATOR : DAUBLE CRYSTAL SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 X 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 68981 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.450 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 11.40 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 25.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.45 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.48 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: HKL-3000 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 34.66 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.88 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.05 M MAGNESIUM CHLORIDE, 0.1 M REMARK 280 HEPES, PH 7.5, 30% PEG550 MME, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 27.35600 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 45.31050 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.85000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 45.31050 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 27.35600 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.85000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 11410 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18030 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -32.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 205 REMARK 465 SER B -2 REMARK 465 ASN B -1 REMARK 465 ALA B 0 REMARK 465 MSE B 1 REMARK 465 THR B 2 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 MSE B 74 N CA C O CB CG SE REMARK 480 MSE B 74 CE REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NZ LYS B 65 OD CSX B 177 1.30 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 47 18.19 55.61 REMARK 500 GLU A 50 56.49 39.80 REMARK 500 PRO A 51 44.10 -86.61 REMARK 500 MSE A 66 -36.29 -38.81 REMARK 500 MSE A 66 -34.99 -38.81 REMARK 500 VAL B 47 16.24 59.84 REMARK 500 GLU B 50 55.99 39.90 REMARK 500 PRO B 51 46.52 -86.81 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7LDQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PUTATIVE NAD(P)H-FLAVIN OXIDOREDUCTASE FROM REMARK 900 HAEMOPHILUS INFLUENZAE R2846 WITH ACETATE IN THE ACTIVE SITE REMARK 900 RELATED ID: IDP97892 RELATED DB: TARGETTRACK DBREF1 7RZL A 1 220 UNP A0A3E1QXW7_HAEIF DBREF2 7RZL A A0A3E1QXW7 1 220 DBREF1 7RZL B 1 220 UNP A0A3E1QXW7_HAEIF DBREF2 7RZL B A0A3E1QXW7 1 220 SEQADV 7RZL SER A -2 UNP A0A3E1QXW EXPRESSION TAG SEQADV 7RZL ASN A -1 UNP A0A3E1QXW EXPRESSION TAG SEQADV 7RZL ALA A 0 UNP A0A3E1QXW EXPRESSION TAG SEQADV 7RZL MSE A 74 UNP A0A3E1QXW LEU 74 CONFLICT SEQADV 7RZL VAL A 102 UNP A0A3E1QXW MET 102 CONFLICT SEQADV 7RZL SER B -2 UNP A0A3E1QXW EXPRESSION TAG SEQADV 7RZL ASN B -1 UNP A0A3E1QXW EXPRESSION TAG SEQADV 7RZL ALA B 0 UNP A0A3E1QXW EXPRESSION TAG SEQADV 7RZL MSE B 74 UNP A0A3E1QXW LEU 74 CONFLICT SEQADV 7RZL VAL B 102 UNP A0A3E1QXW MET 102 CONFLICT SEQRES 1 A 223 SER ASN ALA MSE THR GLN LEU THR ARG GLU GLN VAL LEU SEQRES 2 A 223 GLU LEU PHE HIS GLN ARG SER SER THR ARG TYR TYR ASP SEQRES 3 A 223 PRO ALA LYS LYS ILE SER ASP GLU ASP PHE GLU CYS ILE SEQRES 4 A 223 LEU GLU CYS GLY ARG LEU SER PRO SER SER VAL GLY SER SEQRES 5 A 223 GLU PRO TRP LYS PHE LEU VAL ILE GLN ASN LYS THR LEU SEQRES 6 A 223 ARG GLU LYS MSE LYS SER PHE SER TRP GLY MSE MSE ASN SEQRES 7 A 223 GLN LEU ASP ASN CYS SER HIS LEU VAL VAL ILE LEU ALA SEQRES 8 A 223 LYS LYS ASN ALA ARG TYR ASP SER PRO PHE PHE GLU ASP SEQRES 9 A 223 VAL MSE VAL ARG LYS GLY LEU ASN ALA GLU GLN GLN GLN SEQRES 10 A 223 ALA ALA LEU ALA LYS TYR LYS ALA LEU GLN GLU GLU ASP SEQRES 11 A 223 MSE LYS LEU LEU GLU SER ASP ARG THR LEU PHE ASP TRP SEQRES 12 A 223 CYS SER LYS GLN THR TYR ILE ALA LEU ALA ASN MSE LEU SEQRES 13 A 223 THR GLY ALA ALA ALA LEU GLY ILE ASP SER CYS PRO ILE SEQRES 14 A 223 GLU GLY PHE HIS TYR ASP LYS MSE ASN GLU CYS LEU ALA SEQRES 15 A 223 GLU GLU GLY LEU PHE ASP PRO LYS GLU TYR ALA VAL SER SEQRES 16 A 223 VAL ALA ALA THR PHE GLY TYR ARG SER ARG ASP ILE ALA SEQRES 17 A 223 LYS LYS SER ARG LYS ALA LEU ASP GLU VAL VAL ARG TRP SEQRES 18 A 223 VAL GLU SEQRES 1 B 223 SER ASN ALA MSE THR GLN LEU THR ARG GLU GLN VAL LEU SEQRES 2 B 223 GLU LEU PHE HIS GLN ARG SER SER THR ARG TYR TYR ASP SEQRES 3 B 223 PRO ALA LYS LYS ILE SER ASP GLU ASP PHE GLU CYS ILE SEQRES 4 B 223 LEU GLU CYS GLY ARG LEU SER PRO SER SER VAL GLY SER SEQRES 5 B 223 GLU PRO TRP LYS PHE LEU VAL ILE GLN ASN LYS THR LEU SEQRES 6 B 223 ARG GLU LYS MSE LYS SER PHE SER TRP GLY MSE MSE ASN SEQRES 7 B 223 GLN LEU ASP ASN CYS SER HIS LEU VAL VAL ILE LEU ALA SEQRES 8 B 223 LYS LYS ASN ALA ARG TYR ASP SER PRO PHE PHE GLU ASP SEQRES 9 B 223 VAL MSE VAL ARG LYS GLY LEU ASN ALA GLU GLN GLN GLN SEQRES 10 B 223 ALA ALA LEU ALA LYS TYR LYS ALA LEU GLN GLU GLU ASP SEQRES 11 B 223 MSE LYS LEU LEU GLU SER ASP ARG THR LEU PHE ASP TRP SEQRES 12 B 223 CYS SER LYS GLN THR TYR ILE ALA LEU ALA ASN MSE LEU SEQRES 13 B 223 THR GLY ALA ALA ALA LEU GLY ILE ASP SER CYS PRO ILE SEQRES 14 B 223 GLU GLY PHE HIS TYR ASP LYS MSE ASN GLU CSX LEU ALA SEQRES 15 B 223 GLU GLU GLY LEU PHE ASP PRO LYS GLU TYR ALA VAL SER SEQRES 16 B 223 VAL ALA ALA THR PHE GLY TYR ARG SER ARG ASP ILE ALA SEQRES 17 B 223 LYS LYS SER ARG LYS ALA LEU ASP GLU VAL VAL ARG TRP SEQRES 18 B 223 VAL GLU MODRES 7RZL MSE A 1 MET MODIFIED RESIDUE MODRES 7RZL MSE A 66 MET MODIFIED RESIDUE MODRES 7RZL MSE A 73 MET MODIFIED RESIDUE MODRES 7RZL MSE A 103 MET MODIFIED RESIDUE MODRES 7RZL MSE A 128 MET MODIFIED RESIDUE MODRES 7RZL MSE A 152 MET MODIFIED RESIDUE MODRES 7RZL MSE A 174 MET MODIFIED RESIDUE MODRES 7RZL MSE B 66 MET MODIFIED RESIDUE MODRES 7RZL MSE B 73 MET MODIFIED RESIDUE MODRES 7RZL MSE B 103 MET MODIFIED RESIDUE MODRES 7RZL MSE B 128 MET MODIFIED RESIDUE MODRES 7RZL MSE B 152 MET MODIFIED RESIDUE MODRES 7RZL MSE B 174 MET MODIFIED RESIDUE MODRES 7RZL CSX B 177 CYS MODIFIED RESIDUE HET MSE A 1 8 HET MSE A 66 8 HET MSE A 73 8 HET MSE A 74 16 HET MSE A 103 16 HET MSE A 128 8 HET MSE A 152 8 HET MSE A 174 8 HET MSE B 66 8 HET MSE B 73 8 HET MSE B 74 16 HET MSE B 103 16 HET MSE B 128 8 HET MSE B 152 16 HET MSE B 174 8 HET CSX B 177 7 HET NPO A 301 10 HET EDO A 302 8 HET FMT A 303 3 HET FMN A 304 31 HET EDO A 305 4 HET FMN B 301 31 HET NPO B 302 10 HET EPE B 303 30 HETNAM MSE SELENOMETHIONINE HETNAM CSX S-OXY CYSTEINE HETNAM NPO P-NITROPHENOL HETNAM EDO 1,2-ETHANEDIOL HETNAM FMT FORMIC ACID HETNAM FMN FLAVIN MONONUCLEOTIDE HETNAM EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID HETSYN EDO ETHYLENE GLYCOL HETSYN FMN RIBOFLAVIN MONOPHOSPHATE HETSYN EPE HEPES FORMUL 1 MSE 15(C5 H11 N O2 SE) FORMUL 2 CSX C3 H7 N O3 S FORMUL 3 NPO 2(C6 H5 N O3) FORMUL 4 EDO 2(C2 H6 O2) FORMUL 5 FMT C H2 O2 FORMUL 6 FMN 2(C17 H21 N4 O9 P) FORMUL 10 EPE C8 H18 N2 O4 S FORMUL 11 HOH *263(H2 O) HELIX 1 AA1 ASN A -1 GLN A 3 5 5 HELIX 2 AA2 THR A 5 ARG A 16 1 12 HELIX 3 AA3 SER A 29 LEU A 42 1 14 HELIX 4 AA4 SER A 45 SER A 49 5 5 HELIX 5 AA5 ASN A 59 SER A 68 1 10 HELIX 6 AA6 PHE A 69 GLY A 72 5 4 HELIX 7 AA7 MSE A 73 ASP A 78 1 6 HELIX 8 AA8 SER A 96 ARG A 105 1 10 HELIX 9 AA9 ASN A 109 GLU A 126 1 18 HELIX 10 AB1 LYS A 129 GLU A 132 5 4 HELIX 11 AB2 SER A 133 LEU A 159 1 27 HELIX 12 AB3 HIS A 170 GLU A 181 1 12 HELIX 13 AB4 ALA A 211 VAL A 215 1 5 HELIX 14 AB5 THR B 5 ARG B 16 1 12 HELIX 15 AB6 SER B 29 LEU B 42 1 14 HELIX 16 AB7 SER B 45 SER B 49 5 5 HELIX 17 AB8 ASN B 59 SER B 68 1 10 HELIX 18 AB9 PHE B 69 MSE B 74 5 6 HELIX 19 AC1 ASN B 75 CYS B 80 1 6 HELIX 20 AC2 SER B 96 LYS B 106 1 11 HELIX 21 AC3 ASN B 109 GLU B 126 1 18 HELIX 22 AC4 LYS B 129 GLU B 132 5 4 HELIX 23 AC5 SER B 133 LEU B 159 1 27 HELIX 24 AC6 HIS B 170 GLU B 181 1 12 HELIX 25 AC7 ALA B 211 VAL B 215 1 5 SHEET 1 AA1 5 ASP A 162 ILE A 166 0 SHEET 2 AA1 5 TYR A 189 GLY A 198 -1 O ALA A 194 N ILE A 166 SHEET 3 AA1 5 HIS A 82 LYS A 89 -1 N ILE A 86 O VAL A 193 SHEET 4 AA1 5 TRP A 52 ILE A 57 -1 N LYS A 53 O LEU A 87 SHEET 5 AA1 5 VAL B 216 VAL B 219 1 O VAL B 219 N VAL A 56 SHEET 1 AA2 5 VAL A 216 VAL A 219 0 SHEET 2 AA2 5 TRP B 52 ILE B 57 1 O VAL B 56 N VAL A 219 SHEET 3 AA2 5 HIS B 82 LYS B 89 -1 O VAL B 85 N LEU B 55 SHEET 4 AA2 5 TYR B 189 GLY B 198 -1 O VAL B 193 N ILE B 86 SHEET 5 AA2 5 ASP B 162 ILE B 166 -1 N ILE B 166 O ALA B 194 LINK C ALA A 0 N MSE A 1 1555 1555 1.33 LINK C MSE A 1 N THR A 2 1555 1555 1.33 LINK C LYS A 65 N MSE A 66 1555 1555 1.32 LINK C MSE A 66 N ALYS A 67 1555 1555 1.33 LINK C MSE A 66 N BLYS A 67 1555 1555 1.33 LINK C GLY A 72 N MSE A 73 1555 1555 1.33 LINK C MSE A 73 N AMSE A 74 1555 1555 1.33 LINK C MSE A 73 N BMSE A 74 1555 1555 1.32 LINK C AMSE A 74 N ASN A 75 1555 1555 1.33 LINK C BMSE A 74 N ASN A 75 1555 1555 1.33 LINK C VAL A 102 N AMSE A 103 1555 1555 1.33 LINK C VAL A 102 N BMSE A 103 1555 1555 1.33 LINK C AMSE A 103 N VAL A 104 1555 1555 1.33 LINK C BMSE A 103 N VAL A 104 1555 1555 1.34 LINK C ASP A 127 N MSE A 128 1555 1555 1.33 LINK C MSE A 128 N ALYS A 129 1555 1555 1.33 LINK C MSE A 128 N BLYS A 129 1555 1555 1.34 LINK C ASN A 151 N MSE A 152 1555 1555 1.33 LINK C MSE A 152 N LEU A 153 1555 1555 1.34 LINK C LYS A 173 N MSE A 174 1555 1555 1.33 LINK C MSE A 174 N ASN A 175 1555 1555 1.34 LINK C LYS B 65 N MSE B 66 1555 1555 1.33 LINK C MSE B 66 N LYS B 67 1555 1555 1.34 LINK C GLY B 72 N MSE B 73 1555 1555 1.33 LINK C MSE B 73 N AMSE B 74 1555 1555 1.32 LINK C MSE B 73 N BMSE B 74 1555 1555 1.33 LINK C AMSE B 74 N ASN B 75 1555 1555 1.34 LINK C BMSE B 74 N ASN B 75 1555 1555 1.33 LINK C VAL B 102 N AMSE B 103 1555 1555 1.32 LINK C VAL B 102 N BMSE B 103 1555 1555 1.33 LINK C AMSE B 103 N VAL B 104 1555 1555 1.33 LINK C BMSE B 103 N VAL B 104 1555 1555 1.33 LINK C ASP B 127 N MSE B 128 1555 1555 1.33 LINK C MSE B 128 N LYS B 129 1555 1555 1.33 LINK C ASN B 151 N AMSE B 152 1555 1555 1.33 LINK C ASN B 151 N BMSE B 152 1555 1555 1.33 LINK C AMSE B 152 N LEU B 153 1555 1555 1.34 LINK C BMSE B 152 N LEU B 153 1555 1555 1.34 LINK C LYS B 173 N MSE B 174 1555 1555 1.33 LINK C MSE B 174 N AASN B 175 1555 1555 1.34 LINK C MSE B 174 N BASN B 175 1555 1555 1.33 LINK C GLU B 176 N CSX B 177 1555 1555 1.33 LINK C CSX B 177 N LEU B 178 1555 1555 1.33 CRYST1 54.712 77.700 90.621 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018278 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012870 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011035 0.00000